NCT05695196View on ClinicalTrials.gov

Feasibility and Safety Study of Parent-to-Child Nasal Microbiota Transplant

PHASE1Active, not recruitingINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

October 25, 2023

Primary Completion Date

May 6, 2025

Study Completion Date

December 1, 2025

Conditions
Staphylococcus AureusMicrobial ColonizationNeonatal Infection
Interventions
BIOLOGICAL

nasal microbiota transplant (NMT)

nasal microbiota transplant

BIOLOGICAL

Placebo

Placebo sterile saline

Trial Locations (1)

21287

Johns Hopkins University, Baltimore

All Listed Sponsors
lead

Johns Hopkins University

OTHER

NCT05695196 - Feasibility and Safety Study of Parent-to-Child Nasal Microbiota Transplant | Biotech Hunter | Biotech Hunter